REGENXWELLNESSRestore. Renew. Thrive.

Age verification

Are you 18 or older?

The compounds offered on RegenX Wellness are sold strictly for laboratory and research purposes. They are not intended for human or veterinary consumption. By entering, you confirm you are at least 18 years of age and a qualified researcher.

Research Use Only · Not for Human Consumption
Delivery & Pickup — Melbourne only · Australia-wide delivery coming soon

Research library

The science behind the catalog.

A curated index of peer-reviewed literature for each peptide in our catalog. References are drawn from PubMed-indexed journals and are provided for research reference only.

9 peptides21 referencesVerified against PubMed · February 2026

Research reference only

These citations are provided as scientific reference material. The literature does not constitute medical advice or a recommendation for human use. RegenX Wellness sells peptides strictly for in-vitro laboratory research.

3 papers

Retatrutide (LY3437943)

A novel triple agonist at GLP-1, GIP, and glucagon receptors. Recent landmark trials demonstrate substantial effects on body weight and glycemic control in humans.

  • Jastreboff AM, Kaplan LM, Frías JP, et al.

    Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.

    N Engl J Med · 2023 · 389(6):514–526

    PubMed PMID 37366315
  • Rosenstock J, Frias J, Jastreboff AM, et al.

    Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.

    Lancet · 2023 · 402(10401):529–544

    PubMed PMID 37385280
  • Coskun T, Urva S, Roell WC, et al.

    LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

    Cell Metab · 2022 · 34(9):1234–1247.e9

    PubMed PMID 35985340

2 papers

Tesamorelin

A stabilized GHRH analogue with extensive clinical literature, most notably in studies of visceral adipose tissue and lipid biology.

  • Stanley TL, Feldpausch MN, Oh J, et al.

    Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

    JAMA · 2014 · 312(4):380–389

    PubMed PMID 25038357
  • Falutz J, Allas S, Blot K, et al.

    Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.

    J Clin Endocrinol Metab · 2010 · 95(9):4291–4304

    PubMed PMID 20554713

2 papers

MOTS-c

A mitochondrial-derived peptide implicated in metabolic homeostasis, AMPK signaling, and exercise-induced adaptations.

  • Lee C, Zeng J, Drew BG, et al.

    The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.

    Cell Metab · 2015 · 21(3):443–454

    PubMed PMID 25738459
  • Reynolds JC, Lai RW, Woodhead JST, et al.

    MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.

    Nat Commun · 2021 · 12(1):470

    PubMed PMID 33473109

2 papers

GHK-Cu (Copper Peptide)

A naturally occurring copper-binding tripeptide widely studied in dermal remodeling, collagen biology, and tissue repair research.

  • Pickart L, Vasquez-Soltero JM, Margolina A.

    GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.

    BioMed Research International · 2015 · 2015:648108

    PubMed PMID 26236730
  • Pickart L.

    The human tri-peptide GHK and tissue remodeling.

    J Biomater Sci Polym Ed · 2008 · 19(8):969–988

    PubMed PMID 18644225

2 papers

KPV (α-MSH 11–13)

The C-terminal tripeptide fragment of α-melanocyte-stimulating hormone, studied for anti-inflammatory and mucosal repair properties.

  • Kannengiesser K, Maaser C, Heidemann J, et al.

    Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.

    Inflamm Bowel Dis · 2008 · 14(3):324–331

    PubMed PMID 18092346
  • Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al.

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

    Gastroenterology · 2008 · 134(1):166–178

    PubMed PMID 18061177

2 papers

Semax (ACTH 4–7 analogue)

A heptapeptide analogue of ACTH(4-7) studied for nootropic and neurotrophic effects in the central nervous system.

  • Dolotov OV, Karpenko EA, Inozemtseva LS, et al.

    Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain.

    J Neurochem · 2006 · 97(Suppl 1):82–86

    PubMed PMID 16635254
  • Shadrina MI, Dolotov OV, Grivennikov IA, et al.

    Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog.

    Neurosci Lett · 2001 · 308(2):115–118

    PubMed PMID 11457573

3 papers

BPC-157

A 15-amino-acid peptide derived from a protective protein in gastric juice. One of the most extensively studied peptides in pre-clinical tissue-repair and gastrointestinal research.

  • Sikiric P, Seiwerth S, Rucman R, et al.

    Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.

    Curr Pharm Des · 2011 · 17(16):1612–1632

    PubMed PMID 21548867
  • Chang CH, Tsai WC, Lin MS, et al.

    The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

    J Appl Physiol (1985) · 2011 · 110(3):774–780

    PubMed PMID 21030672
  • Sikiric P, Seiwerth S, Rucman R, et al.

    Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.

    Curr Neuropharmacol · 2016 · 14(8):857–865

    PubMed PMID 27138887

3 papers

KLOW (multi-peptide blend)

KLOW is a research-only multi-peptide blend; no single peer-reviewed paper exists for the formulated combination. Below are key references for the individual peptide components.

  • KPV

    Kannengiesser K, Maaser C, Heidemann J, et al.

    Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.

    Inflamm Bowel Dis · 2008 · 14(3):324–331

    PubMed PMID 18092346
  • BPC-157

    Sikiric P, Seiwerth S, Rucman R, et al.

    Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.

    Curr Pharm Des · 2011 · 17(16):1612–1632

    PubMed PMID 21548867
  • GHK-Cu

    Pickart L, Vasquez-Soltero JM, Margolina A.

    GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.

    BioMed Research International · 2015 · 2015:648108

    PubMed PMID 26236730

2 papers

Ipamorelin

A selective growth-hormone secretagogue and ghrelin mimetic, studied for its pulsatile GH-releasing effect with minimal cortisol or prolactin response.

  • Raun K, Hansen BS, Johansen NL, et al.

    Ipamorelin, the first selective growth hormone secretagogue.

    Eur J Endocrinol · 1998 · 139(5):552–561

    PubMed PMID 9849822
  • Sinha DK, Balasubramanian A, Tatem AJ, et al.

    Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.

    Transl Androl Urol · 2020 · 9(Suppl 2):S149–S159

    PubMed PMID 32257855

Want a citation we’ve missed? Email info@regenxwellness.com.au with the reference and we’ll add it.

← Back home